GuildLink drives MedAdvisor revenue growth

Medication management platform, MedAdvisor’s acquisition of GuildLink is bearing fruit with the former Guild Group subsidiary making a significant contribution to the firm’s revenue growth.   Announcing its 2023 financial year second quarter results (to 31 December 2022) to the Australian Securities Exchange (ASX), MedAdvisor CEO, Rick Ratliff, revealed global revenue was up 89.9 per

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous New HCF deal promises cheaper Ramsay pharmacy prices
Next Technology lagging on pharmacists’ needs